U.S. Automated Breast Ultrasound Systems Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034

U.S. Automated Breast Ultrasound Systems Market was valued at USD 758.3 million in 2024 and is estimated to grow at a CAGR of 16% to reach USD 3.3 Billion by 2034.

The market is witnessing strong momentum due to the increasing number of breast cancer cases across the country, continuous advancements in imaging technologies, rising reimbursement coverage, and growing government initiatives promoting early diagnosis. Automated breast ultrasound systems (ABUS) are revolutionizing diagnostic imaging by offering high-resolution, 3D scans that improve the detection of lesions, particularly in patients with dense breast tissue. These systems deliver consistent, operator-independent results and provide a comfortable and non-invasive alternative to conventional screening methods. The shift toward patient-centric healthcare and the growing need for accurate, reproducible imaging are prompting hospitals and diagnostic facilities to adopt ABUS solutions. The rising awareness of breast cancer screening, combined with supportive policies and clinical acceptance, is further accelerating the adoption of automated systems nationwide. Increasing prevalence of invasive breast cancer continues to be a major factor propelling market growth, alongside the integration of advanced software and AI-driven imaging analysis in ABUS platforms.

The ABUS segment generated USD 482.3 million in 2024 and is expected to reach USD 2.1 Billion by 2034. The growth is largely supported by the growing preference for artificial intelligence-enhanced imaging technologies and greater accessibility of automated solutions in diagnostic centers and hospitals across the U.S. Automated breast volume scanners (ABVS) offer comprehensive three-dimensional visualization, enabling more precise identification of abnormalities in patients with dense breast tissue. Integration with digital and AI-based platforms further ensures faster image acquisition and improved diagnostic reliability, contributing to increased adoption across healthcare institutions.

The diagnostic imaging centers segment held 30.1% share and is projected to grow at a CAGR of 16.3% through 2034. This segment continues to lead market growth owing to its specialized imaging capabilities and the ability to provide high-accuracy diagnostic services. Diagnostic imaging centers play a crucial role in breast cancer detection programs, offering advanced automated imaging solutions that outperform conventional screening techniques, particularly for patients requiring high-clarity visualization and consistent reporting.

Key players actively shaping the U.S. Automated Breast Ultrasound Systems Market include Siemens Healthineers, QView Medical, Supersonic Imagine, MetriTrack, Seno Medical Instruments, Canon, Shantou Institute of Ultrasonic Instruments, Hitachi, Delphinus Medical Technologies, Hologic, CapeRay Medical, Koninklijke Philips, GE Healthcare, Theraclion, and SonoCine. Leading manufacturers are focusing on product innovation, digital integration, and strategic partnerships to enhance their market position. Companies are developing AI-powered imaging technologies to improve diagnostic precision and workflow efficiency. Investments in research and development are accelerating the creation of user-friendly and patient-centered systems. Collaborations with hospitals, imaging centers, and technology firms are helping expand clinical adoption and streamline regulatory compliance. Firms are also emphasizing product differentiation through ergonomic designs, cloud-based data management, and compatibility with existing imaging infrastructure. In addition, mergers, acquisitions, and regional expansion strategies are being leveraged to strengthen distribution networks and reinforce market leadership across the U.S. automated breast ultrasound systems landscape.